Please login to the form below

Not currently logged in
Email:
Password:

US government

This page shows the latest US government news and features for those working in and with pharma, biotech and healthcare.

FDA approves Bavarian Nordic’s smallpox and monkeypox vaccine

FDA approves Bavarian Nordic’s smallpox and monkeypox vaccine

This means that the citizens in the US, like many countries, have no immunity to the disease. ... This approval reflects the US government’s commitment to preparedness through support for the development of safe and effective vaccines, therapeutics and

Latest news

  • Democrats’ final pricing plan announced, 250 drugs targeted Democrats’ final pricing plan announced, 250 drugs targeted

    Would allow US federal government to negotiate prices of key medicines. ... Drug pricing in the US has been under scrutiny, with drugs prices, including insulin, increasing exponentially.

  • Novo follows Sanofi, Lilly with insulin price cut in US Novo follows Sanofi, Lilly with insulin price cut in US

    The Danish drugmaker says it will offer an authorised generic version of NovoLog (insulin aspart) at around $145 per vial, roughly half the branded drug’s current US list price, from ... This prompted the US government to look into ways to reduce costs,

  • AZ and Novartis ‘most exposed’ to Senate pricing proposals AZ and Novartis ‘most exposed’ to Senate pricing proposals

    The reference pricing concept drew swift condemnation from industry, but Jefferies suggests that while it is generally considered prices outside the US are cheaper, once government reimbursement programmes are taken into ... account “net prices overall

  • Reckitt hammered by $1.4bn opioid settlement bill Reckitt hammered by $1.4bn opioid settlement bill

    Case centres on Subaxone marketing practices. Reckitt Benckiser (RB) has agreed to pay an eye-watering $1.4bn to the US government to resolve criminal and civil litigation over the marketing ... The US government alleged that the pharma unit made

  • Novartis close to US bribery settlement Novartis close to US bribery settlement

    Company faces huge damages pay out. Novartis and the US federal government are close to agreeing a deal to settle allegations that the company offered kickbacks to doctors in return for ... The story was broken by STAT News' Pharmalot blog, which

More from news
Approximately 3 fully matching, plus 195 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    However the company, like many others, is at the mercy of the US government shutdown, which means many FDA staff are on unpaid leave, and threatens drug approval timelines if it ... Its early US take-up is encouraging, according to Shire, with Q3 sales

  • China’s clinical trial shake-up China’s clinical trial shake-up

    In 2007, 1% of trials registered on US government portal ClinicalTrials. ... Perhaps most importantly, China has moved to a US-style clinical trial application (CTA) system that guarantees sponsors will wait no more than 60 days to learn whether they can

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    By January 2018, the US Centers for Disease Control and Prevention had reported 29 cases of MCR resistance identified across 15 states of the USA. ... Alongside this, there have been equally important initiatives by the World Health Organization (WHO),

  • US health reforms US health reforms

    Meanwhile, the global industry waits with bated breath upon a recently elected, mercurial US federal government that whipsaws from one extreme to the other, sometimes within the hour. ... is a freelance writer based in the Philadelphia metro area of the

  • Brexit: the facts (and the alternative facts) Brexit: the facts (and the alternative facts)

    The only ‘fact’ is that ‘Brexit means Brexit’… so the Government tell us. ... Two post-referendum announcements have boosted the UK Government. GSK announced a £275 million investment in its UK manufacturing sites and Alnylam, a US biotech

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

  • Portland Health appoints Alfred Jackson as a partner Portland Health appoints Alfred Jackson as a partner

    In addition to his work in healthcare, Jackson also has broad experience in public affairs and government relations. ... agency experience, senior leadership and strategic relationships across the health and government sectors to deepen our offering to

  • Former Sanofi exec Joseph Devaney joins Astellas Former Sanofi exec Joseph Devaney joins Astellas

    He becomes government affairs and policy, Americas VP. Astellas has appointed Joseph Devaney as vice president of government affairs and policy for its Americas business. ... In this role, Devaney will be responsible for developing, communicating and

  • Pfizer’s CMO joins board of Tenet Pfizer’s CMO joins board of Tenet

    Freda Lewis-Hall to advise healthcare services firm. US healthcare services company Tenet Health Corporation has added pharma experience to its board with the appointment of Pfizer's chief medical officer ... In addition to her role at Pfizer Dr

  • Sanofi appoints NIH’s Gary Nabel as chief scientific officer Sanofi appoints NIH’s Gary Nabel as chief scientific officer

    He previously headed vaccine research centre of the US National Institute of Allergy and Infectious Diseases. ... Dr Nabel leaves the NIH, which is part of the US government's department of health, after 13 years as director of the vaccine research

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Genetic counsellors: the new healthcare influencers?

    The US government will cover the costs, signalling their commitment to more precise treatment that will drive better outcomes for patients across the U.S. ... There are more than  70, 000  different genetic testing products available on the US market

  • To track disease, follow the money

    of US banknotes, which are carried and passed on by people in the same way as disease. ... Lower-denomination banknotes are more likely to be contaminated (perhaps because they are more widely handled).(7)  A US government survey found that that 94% of

  • Could hackers threaten your health?

    In this year’s Def Con hacking conference, representatives from the US FDA, the government body responsible for the security of medical devices, spoke for the first time. Attempting to spark

  • Focus on Rare Diseases

    The US government passed the Orphan Drug Act in 1983, and it was subsequently adopted in other key markets, most notably in Japan in 1993 and the European Union in 2000.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics